TARPLIN, DOWNS & YOUNG, LLC

Lobbying for NEUROCRINE BIOSCIENCES, INC. · Science focused biopharma company focused on neuro, endo and psych disorders

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $80,000.00 income · posted Jan 20, 2026

Lobbying activity 3

Health Issues

IRA, prescription drug pricing, payment reform, innovation

Medicare/Medicaid

telehealth, mental health, prescription drug pricing, payment reform

Budget/Appropriations

federal budget issues

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.